Pharmacology Lecture 6_Drug Toxicity Flashcards
Describe a dose dependent pathological ADR
This is an ADR where a toxic metabolite of a drug acumulates and causes damage seperate from the target phyisiology (example acetominophen)
What is a TDx
a TDx is the dose at which x percentage of the population will experience a toxic effect from a drug. TD50 would equate to 50% of the population experiencing drug toxicity
What are the three considerations for drugs with a low TI
1) Monitor blood levels of drug
2) is the drug necessary (is it having its intended effect)
3) Monitor health of target organs
What is a toxic threshold
It is defined as the TD1 (this is essentiall the dose at which side effects first begine to appear in your population.
How is a drug margin of safety calculated?
it is the LD1/ED99. Note a larger MOS equates to a safer drug from a dose dependent standpoint (this does not take into account allergic responces)
Define a type 2 allergic rxn “Cytolitic rxn”
An antigen binds to a red blood cell. An antibody 9IgM or IgE) then binds to the antigen. This triggers cytotoxic t cell or complement mediated lysing of the red blood cell.
Define a type 1 allergic rxn “hypersensitive alergic reaction”
This is an anaphylactic rxn. A protien bound hapten (or just hapten) bind to a Mast cell bound IgE which causes the mast cell to release inflamitory mediators including hitamine, serotonin, and leukotriens
What is an “Off target ADR”
these result in an unintended interaction with an unintended receptor
What are 5 clinical settings when drug-drug interactions (DDI) are most likely to occure?
1) Drugs with low TI
2) When multipul drugs are being taken (esp>10)
3) When patient has comprimised renal, hepatic, or pulminary function
4) When patient has immunodeficency syndrome
5) When Patient has behavioral of psychiatric disorders (esp drug abuse)
Define “Apparent dose”
Apparent dose is the dose that would have resulted in a given blood drug concentration under “normal” conditions (ie the patient does not have an unusaual ADME)
What 5 steps can be taken to prevent DDIs?
1) Document all drugs being taken
2) Minimize # of drugs being taken
3) Extreme caution with low TI drugs
4) Look for adverse DIs in differential
5) Use caution with patients that have comprimised organ function
How is the therapeutic window defined
it is the range bounded by the ED9 and ED91
What are three serum enzyme levels you can check to determine hepatotoxicity?
Alinine aminothransferase (ALT) Aspartate aminothransferase (AST) Alkaline phosphatase (ALP)
All three enzymens are hepatocyte celular enzymes. Their presence in serum indicates damage to liver cells
Define a type 4 allergic rxn “delayed hyper sensitivity rxn”
An allergen is phagocytosed and travles to a lymph node to be presented to a t cell. The t cell triggers an immune response. Repeated exposures can trigger a cytokine storm.
Define a tye 3 allergic rxn “Arthus rxn”
Antigen bound antibodies (IgM or IgG) get depositied on the surface of the endothelium of the vasculature. This attractrs macrophages which release inflamitory cytokines. This can lead to necrosis which is very bad.
List 5 factors that effect oral drug absorbtion
Motility (slower motility leads to increased absorbtion), Gastric PH (think ion trapping), blood albumin levels (lower albumin levels lead to increased free drug avaiable), impaired renal function (reduces elimination of drug from the body), impaired hypatocyte function (reduced metabolism of drug)
What is a test that can be run to verify nephrotoxicity?
Urine creatinine levels. Low cratinine levels are indicitive of reduced kidney function.
What are some of the patient specific factors that effect the quantitiy of drug in the blood
Absorbtion, Distribution, Metabolisium, Elimination (ADME)
Describe a dose dependent pharmacological ADR
This is an ADR where the target physiology is pushed to far
What is an “On target ADR” list three
An “On Target ADR” is when the adverse drug response results from stimulating the intended receptor. this includes overdose, correct receptor in the wrong tissue, and inhabition/activation from chromic drug exposure